HUMAN HEALTH (01419) releases interim results, with a net profit attributable to shareholders of 16.822 million Hong Kong dollars, a decrease of 16.03% year-on-year.

HUMAN HEALTH (01419) announced its interim performance for the six months ending December 31, 2024, with a revenue of HK$316 million, an increase of 6.98% year-on-year; a profit attributable to shareholders of HK$16.822 million, a decrease of 16.03% year-on-year; and earnings per share of 4.4 HK cents. The announcement stated that revenue generated from the group's general medical services increased by approximately HK$7.7 million or 3.9% from the interim of the 2024 fiscal year to approximately HK$207 million in the interim of the 2025 fiscal year. This growth was mainly attributed to an increase in patient visits for general medical services.